Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis
NCT ID: NCT04921696
Last Updated: 2023-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2021-07-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relationship Between Erythrocyte Transfusion and Nutrition and Necrotizing Enterocolitis in Preterm Infants
NCT04083638
RBC Irradiation, Anemia and Gut Injury
NCT02741648
Withholding Feeds During Red Blood Cell Transfusion and TRAGI
NCT02132819
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
NCT03919500
Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity
NCT02822027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This prospective study examined whether RBC transfusion and anemia were associated with the rate of NEC. The primary objective was to test whether NEC was increased in infants receiving RBC transfusion compared with non transfused infants. Further, exposure to severe neonatal anemia was examined as an independent risk factor for NEC.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RBC transfusion
RBC was transfused to the infants.
RBC transfusion
RBC was transfused to the infants.
no-RBC transfusion
RBC was not transfused to the infants.
no-RBC transfusion
RBC was not transfused to the infants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RBC transfusion
RBC was transfused to the infants.
no-RBC transfusion
RBC was not transfused to the infants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the level blood bilirubin reached the criteria of transfusion therapy
Exclusion Criteria
* receipt of transfusion before enrollment
* parents' decision not to participate
* infant not expected to survive beyond 7 days of life based on the assessment by the treating neonatologist
1 Minute
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Chongqing Medical University
OTHER
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chen Long,MD
director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NECandRBC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.